$FPRX FIVE PRIME THERAPEUTICS, INC. Insider Trading Week 16/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIVE PRIME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in FIVE PRIME THERAPEUTICS, INC. in week 16/2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 11.97 | 58,000 | 694,260 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 18.69 | 45,000 | 841,050 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 19.25 | 75,000 | 1,443,750 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 11.14 | 25,521 | 284,304 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 10.77 | 3,209 | 34,561 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 7.26 | 12,063 | 87,577 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 5.54 | 9,142 | 50,647 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 8.49 | 4,747 | 40,302 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | D | 38.00 | 795 | 30,210 | 0 | 795 to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | D | 38.00 | 795 | 30,210 | 0 | 795 to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | D | 38.00 | 795 | 30,210 | 0 | 795 to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | D | 38.00 | 169,468 | 6,439,784 | 0 | 169.5 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 66,000 | 0 | 169,468 | 103.5 K to 169.5 K (+63.79 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 14,174 | 0 | 103,468 | 117.6 K to 103.5 K (-12.05 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 2,460 | 0 | 117,642 | 120.1 K to 117.6 K (-2.05 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 1,440 | 0 | 120,102 | 121.5 K to 120.1 K (-1.18 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 795 | 0 | 795 | 0 to 795 |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 795 | 0 | 795 | 0 to 795 |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 795 | 0 | 795 | 0 to 795 |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 2,385 | 0 | 121,542 | 123.9 K to 121.5 K (-1.92 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 12.47 | 185,000 | 2,306,950 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Sell | D | 38.00 | 138,947 | 5,279,986 | 0 | 138.9 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 66,000 | 0 | 138,947 | 72.9 K to 138.9 K (+90.48 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | D | 5.78 | 20,000 | 115,600 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | D | 11.97 | 58,000 | 694,260 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | D | 18.69 | 50,000 | 934,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Option Exercise | D | 37.89 | 60,000 | 2,273,400 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Sell | D | 38.00 | 135,547 | 5,150,786 | 0 | 135.5 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Grant | A | 0.00 | 66,000 | 0 | 135,547 | 69.5 K to 135.5 K (+94.90 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | EVP and Chief Medic ... | Gift | G | 0.00 | 8,085 | 0 | 69,547 | 77.6 K to 69.5 K (-10.41 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Option Exercise | D | 5.25 | 25,000 | 131,250 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Option Exercise | D | 11.58 | 30,000 | 347,400 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | White David | See Remarks | Sell | D | 38.00 | 33,423 | 1,270,074 | 0 | 33.4 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 4.47 | 27,769 | 124,127 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 2.80 | 52,408 | 146,742 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 5.23 | 37,998 | 198,730 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 5.31 | 40,868 | 217,009 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 3.94 | 49,552 | 195,235 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 3.23 | 50,367 | 162,685 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 3.99 | 46,939 | 187,287 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 3.79 | 34,451 | 130,569 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 29.80 | 10,000 | 298,000 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 22.15 | 12,500 | 276,875 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | D | 11.65 | 16,600 | 193,390 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Gift | G | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 29.80 | 10,000 | 298,000 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 22.15 | 12,500 | 276,875 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Sell | D | 38.00 | 5,000 | 190,000 | 0 | 5 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 29.80 | 10,000 | 298,000 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 37.99 | 25,000 | 949,750 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | D | 29.80 | 10,000 | 298,000 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | D | 22.15 | 12,500 | 276,875 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | D | 12.70 | 12,500 | 158,750 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Nicholson Garry A | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Nicholson Garry A | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Nicholson Garry A | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Nicholson Garry A | Director | Option Exercise | D | 29.80 | 15,000 | 447,000 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | SCHAFER CAROL | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | SCHAFER CAROL | Director | Option Exercise | D | 6.09 | 1,250 | 7,613 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | SCHAFER CAROL | Director | Option Exercise | D | 9.17 | 25,000 | 229,250 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Lyons-Williams Lori | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Lyons-Williams Lori | Director | Option Exercise | D | 6.30 | 25,000 | 157,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Civik Thomas | President and CEO | Option Exercise | D | 2.72 | 480,000 | 1,305,600 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Civik Thomas | President and CEO | Sell | D | 38.00 | 68,971 | 2,620,898 | 0 | 69 K to 0 (-100.00 %) |